Safer alternatives include optimising tirzepatide monotherapy with appropriate dose titration, structured NHS lifestyle programmes, licensed GLP-1 receptor agonists like semaglutide (Wegovy), or referral for bariatric surgery assessment
There's SO much information to take in that I watched many slides two-three times, and took copious notes
They can offer critical guidance and education for consumers who receive these drugs on how to administer them appropriately and what side effects may look like
In this article, we delve into what BPC 157 is, how it might benefit arthritis patients, and considerations for incorporating it into your wellness plan
Zepbound (tirzepatide): Manufactured by Eli Lilly and FDA-approved for chronic weight management, Zepbound contains the same active ingredient as Mounjaro and has been referenced in current GLP-1 litigation
It stimulates GH release, which in turn promotes lipolysis the breakdown of stored fat for energy